An agreement reached in 2003 relaxed domestic market requirements and allows developing countries to export to other countries with a public health problem as long as exported drugs are not part of a trade or industrial policy.  Drugs exported under such regulations may be packaged or coloured differently to prevent them from affecting the markets of industrialized countries. If your copyright is created with your original work in New Zealand, it will also be recognized in accordance with the copyright laws of countries that have international agreements with New Zealand. The document published by Deputy Trade Minister Judith Tizard proposes that New Zealand support an amendment to international drug and intellectual property rights agreements by adopting a protocol amending the agreement on trade-related ip rights (TRIPS) on the implementation of the Doha Declaration on TRIPS and Public Health. New Zealand is a party to several international agreements, including: unlike other IP agreements, TRIPS have an effective enforcement mechanism. States can be disciplined by the WTO dispute settlement mechanism. Separate standards also apply to due process when parties agree to protect the PGI through trade agreements. These provisions benefit New Zealand exporters who apply common descriptor conditions for the marketing of their products abroad, ensuring that they have sufficient opportunity to comment on the conditions that the contracting parties to the TPP intend to protect through trade agreements. Unlike the previous TPP agreement, the CPTP does not ask New Zealand to do so: the 2002 Doha Declaration confirmed that the TRIPS agreement should not prevent members from taking the necessary measures to protect public health.
Despite this recognition, less developed countries have argued that flexible TRIPS provisions, such as mandatory licensing, are almost impossible to obtain. The least developed countries, in particular, have made their young domestic manufacturing and technological industries proof of the infallible policy. An original copyrighted work in New Zealand is generally protected by the laws of countries that are also members of these agreements. In addition to the basic intellectual property standards set out in the TRIPS agreement, many nations have committed to bilateral agreements to adopt a higher level of protection. This collection of standards, known as TRIPS or TRIPS-Plus, can take many forms.  Among the general objectives of these agreements, New Zealand is a party to various international copyright agreements, which establish minimum standards for copyright protection. Trips-plus conditions, which impose standards beyond TRIPS, have also been verified.  These free trade agreements contain conditions that limit the ability of governments to introduce competition for generic drug manufacturers. In particular, the United States has been criticized for promoting protection far beyond the standards prescribed by the TRIPS. The U.S. free trade agreements with Australia, Morocco and Bahrain have expanded patentability by making patents available for new uses of known products.  The TRIPS agreement authorizes the granting of compulsory licences at the discretion of a country.